Bowe, & Alex Sox-Harris Center for Innovation to Implementation - - PowerPoint PPT Presentation

bowe alex sox harris
SMART_READER_LITE
LIVE PREVIEW

Bowe, & Alex Sox-Harris Center for Innovation to Implementation - - PowerPoint PPT Presentation

Andrea Finlay, PhD, Laura Ellerbe, Anna Rubinsky, Shalini Gupta, Tom Bowe, & Alex Sox-Harris Center for Innovation to Implementation (Ci2i) VA Palo Alto Health Care System National Center on Homelessness Among Veterans Department of


slide-1
SLIDE 1

Andrea Finlay, PhD, Laura Ellerbe, Anna Rubinsky, Shalini Gupta, Tom Bowe, & Alex Sox-Harris

Center for Innovation to Implementation (Ci2i) VA Palo Alto Health Care System National Center on Homelessness Among Veterans Department of Veterans Affairs June 26, 2017

slide-2
SLIDE 2

Disclosures

 Employed and funded 100% by the Department of Veterans Affairs.  No other disclosures.

Funding Sources: Health Services Research & Development (HSR&D) QUERI Rapid Response Project (RRP 12-468) HSR&D Career Development Award (CDA 13-279, PI: Finlay) HSR&D Research Career Scientist (RCS 14-232, PI: Harris) Role of the funding source: The views expressed in this presentation are those of the authors and do not necessarily reflect the position nor policy

  • f the Department of Veterans Affairs (VA) or the United States

government.

slide-3
SLIDE 3

Alcohol use disorder is common among veterans

 6% of VA patients have alcohol use disorder (AUD),

representing over 300,000 veterans (Harris et al., 2012)

 AUD is more prevalent among special populations

 33% of veterans exiting prison (Finlay et al., 2015)  57% of veterans exiting jails or in treatment courts (Finlay et al., 2014)  49% of veterans receiving homeless services (Tsai et al., 2014)

slide-4
SLIDE 4

VA Residential Treatment

 For veterans who need intensive treatment and

supervision, VA provides residential treatment

 63 Substance Use Disorder (SUD) Residential

Rehabilitation Treatment Programs (RRTPs)

 34 Mental Health Residential Rehabilitation Treatment

Programs with an SUD track

 Pharmacotherapy for AUD - naltrexone, acamprosate,

topiramate, and disulfiram – is mandated to be available and considered but use varies widely in residential treatment

slide-5
SLIDE 5

Barriers and Facilitators to Pharmacotherapy for AUD

 Barriers

 Program treatment philosophy  Lack of access to prescribing physicians  Lack of training or knowledge about addiction medications  Low perceived patient demand

 Facilitators

 More education to patients and providers  Increased involvement of physicians in alcohol treatment

(Harris et al., 2013; Oliva et al., 2011)

slide-6
SLIDE 6

Research Question

 What are the perceived barriers to and facilitators of

pharmacotherapy for AUD in VA residential treatment programs?

slide-7
SLIDE 7

Conceptual Framework

Consolidated Framework for Implementation Research (CFIR)

 Inner setting - cultural or structural context in which the

implementation occurs

 Outer setting – external policies and incentives, patients needs and

resources

 Characteristics of individuals – knowledge and beliefs about the

intervention, other personal attributes, self-efficacy

 Intervention characteristics – key aspects of intervention that

influence success of implementation

 Process – planning, execution, evaluation of implementation

(Damschroeder et al., 2009)

slide-8
SLIDE 8

Methods

 Sample

 63 directors, program managers, and/or staff from 44 of

97 VA residential programs

 Qualitative Interviews

 Using fiscal year 2012 VA administrative data, a program

profile was calculated for each residential program

 Unique profile was shared with participants at the start

  • f the interview alongside data on the national program

average

 Interviews were audiotaped and transcribed

slide-9
SLIDE 9

Methods

 Interviews

 Participants from programs with low rates of receipt of

pharmacotherapy for AUD were asked about barriers to receipt of these medications

 Participants from programs with high rates of receipt of

pharmacotherapy for AUD were asked about facilitators to receipt of these medications

 All programs were asked about their overall approach or

philosophy to addiction pharmacotherapy

 Analysis

 Thematic analysis to identify barriers and facilitators (Braun &

Clark, 2006; Vaismoradi et al., 2013)

 Themes were organized and matched with domains and

constructs from the CFIR

slide-10
SLIDE 10

Results - Context

 15,056 patients admitted to residential SUD treatment

programs who were diagnosed with AUD in FY2012

 12 to 689 patients per program  12% average rate of receipt of pharmacotherapy for

AUD

 0% to 50% across programs

slide-11
SLIDE 11

Inner Setting

 Culture – General norms/program philosophy

 Negative program norms (barrier)  Passive openness/interest (facilitator)  Active encouragement/promotion (facilitator)

 Implementation Climate – shared receptivity of

prescriber to intervention

 Negative receptivity to pharmacotherapy (barrier)  Passive openness/interest (facilitator)  Active encouragement/promotion (facilitator)

slide-12
SLIDE 12

Inner Setting

 Implementation Climate - Learning Climate

 Prescriber education (facilitator)  Program staff education (facilitator)

 Readiness for Implementation – Available Resources

 Access to prescribers/specialists (barrier & facilitator)

 Readiness for Implementation – Leadership Climate

 Leadership support or lack thereof (barrier & facilitator)

slide-13
SLIDE 13

Inner Setting

 Networks & Communication

 Initiated by referring programs (facilitator)  Care coordination within residential program (barrier &

facilitator)

 Care coordination with outside providers/programs

(barrier & facilitator)

slide-14
SLIDE 14

Outer Setting

 Patient needs & resources

 Perceived patient attitudes/needs/interest (barrier &

facilitator)

 Patient education (facilitator)

 External policies & incentives

 Policy restrictions (barrier)

slide-15
SLIDE 15

Characteristics of Individuals & Intervention Characteristics

 Knowledge & belief of intervention

 Limitations in prescriber/staff knowledge (barrier)

 Cost

 Cost restriction (barrier)

slide-16
SLIDE 16

 Education and training for providers and patients

 Academic detailing improved prescribing of

pharmacotherapy for AUD (Harris et al., 2016)

 Increase care coordination across settings

Conclusions

slide-17
SLIDE 17

Questions?

17

Contact information: Andrea Finlay Andrea.Finlay@va.gov

slide-18
SLIDE 18

References Cited

Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77-101 Damschroder, L. J., Aron, D. C., Keith, R. E., Kirsh, S. R., Alexander, J. A., & Lowery, J. C. (2009). Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci, 4, 50 Finlay, A. K., Smelson, D., Sawh, L., McGuire, J., Rosenthal, J., Blue-Howells, J., . . . Harris, A. H. S. (2014). U.S. Department of Veterans Affairs Veterans Justice Outreach program: connecting justice-involved veterans with mental health and substance use disorder treatment. Criminal Justice Policy Review, 27(2), 203-222 Finlay, A. K., Stimmel, M., Blue-Howells, J., Rosenthal, J., McGuire, J., Binswanger, I., . . . Timko, C. (2015). Use of Veterans Health Administration mental health and substance use disorder treatment after exiting prison: the Health Care for Reentry Veterans program. Administration and Policy in Mental Health Harris, A. H. S., Bowe, T., Hagedorn, H., Nevedal, A., Finlay, A. K., Gidwani, R., . . . Christopher, M. M. (2016). Interrupted time-series analysis of a multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder. Addiction Science & Clinical Practice, 11(1), 15. Harris, A. H. S., Ellerbe, L., Reeder, R. N., Bowe, T., Gordon, A. J., Hagedorn, H., . . . Trafton, J. A. (2013). Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers. Psychol Serv, 10(4), 410-419. Harris, A. H. S., Oliva, E. M., Bowe, T., Humphreys, K. N., Kivlahan, D. R., & Trafton, J. A. (2012). Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: Patterns of receipt and persistence. Psychiatric Services, 63(7), 679-685. Oliva, E. M., Maisel, N. C., Gordon, A. J., & Harris, A. H. (2011). Barriers to use of pharmacotherapy for addiction disorders and how to overcome them. Curr Psychiatry Rep, 13(5), 374-381. Tsai, J., Kasprow, W. J., & Rosenheck, R. A. (2014). Alcohol and drug use disorders among homeless veterans: prevalence and association with supported housing outcomes. Addict Behav, 39(2), 455-460. Vaismoradi, M., Turunen, H., & Bondas, T. (2013). Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study. Nurs Health Sci, 15(3), 398-405.